biotech Tony Daltorio: Jim O'Neill, the former chief economist at Goldman Sachs, is best known for coining the BRIC acronym, which stands for the emerging market countries Brazil, Russia, India and China.
GlaxoSmithKline plc LON:GSK this morning announced the outcome of the meeting of the Pulmonary Allergy Drugs Advisory Committee of the United States (US) Food and Drug Administration (FDA) regarding the Biologics Licence Application (BLA) for ...
Glaxosmithkline Plc (NYSE:GSK) has received a short term rating of strong sell from research analysts at Zacks with a rank of 5. The company has been rated an average of 2.63 by 8 Wall Street Analysts.
It was announced by GlaxoSmithKline plc. (ADR) (NYSE:GSK) that the company will be investing $95 million for the purpose of establishing a research institute by the name of Altius Institute for Biomedical Sciences in Seattle.
In the last 12 months, GlaxoSmithKline plc (ADR) (NYSE:GSK) generated 20.78% using assets of the company. Reuters provide figures showing that industry's suggest 12.74% and broadly in sector 8.32% seems favorable.